News
Latest News, Announcements, and Press Releases
23Dec 19
Codexis Announces License Agreement with Roche for Enzyme Used in Next Generation Sequencing
REDWOOD CITY, Calif. , Dec. 23, 2019 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces a license agreement to provide Roche with Codexis’ EvoT4 TM DNA ligase high-performance molecular diagnostic enzyme. This enzyme was developed…
read more05Dec 19
Codexis Announces the Publication with Merck of an Efficient Enzymatic Cascade Process for Synthesis of Investigational Anti-HIV Agent, Islatravir
REDWOOD CITY, Calif. , Dec. 05, 2019 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces the publication with Merck , known as MSD outside the United States and Canada , of a paper in the…
read more05Nov 19
Codexis Reports Third Quarter 2019 Financial Results
Total revenues rose 29% to $21.9 million driven by strength in R&D, product, and CodeEvolver ® licensing revenues Eleven customers each contributed at least a quarter million dollars in revenue Conference call begins at 4:30 pm Eastern time today REDWOOD…
read more05Nov 19
Codexis to Participate in Four Investment Conferences in November
REDWOOD CITY, Calif. , Nov. 05, 2019 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that management will participate in four upcoming investment conferences: 10 th Annual Craig-Hallum Alpha Select Conference on Tuesday, November 12,…
read more29Oct 19
Codexis to Hold Third Quarter 2019 Conference Call on November 5
REDWOOD CITY, Calif. , Oct. 29, 2019 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that it will report third quarter 2019 financial results after market close on Tuesday, November 5, 2019 . Codexis management…
read more15Oct 19
Codexis’ Protein Engineering Forum Highlights Progress and Future Direction of the Field
Industry and academic leaders convened to discuss the direction of protein engineering for a wide range of applications REDWOOD CITY, Calif. , Oct. 15, 2019 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, assembled approximately 150…
read more26Sep 19
Codexis Spreading the Promise of Engineered Proteins at SynBioBeta Summit
REDWOOD CITY, Calif. –(BUSINESS WIRE)–Sep. 26, 2019– Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, is contributing resources and expertise to communicate protein engineering’s vast potential at SynBioBeta’s Global Synthetic Biology Summit in San Francisco , Oct. 1–3.
read more26Sep 19
Codexis to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
REDWOOD CITY, Calif. , Sept. 26, 2019 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that management will present at the 2019 Cantor Fitzgerald Global Healthcare Conference on Friday, October 4 at 12:00 p.m. Eastern…
read more06Aug 19
Codexis Reports Second Quarter 2019 Financial Results
Product revenue up 68%; R&D revenue spread over wider base of customers and markets Conference call begins at 4:30 pm Eastern time today REDWOOD CITY, Calif. , Aug. 06, 2019 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq: CDXS), a leading protein…
read more06Aug 19
Codexis Names Ross Taylor Senior Vice President and Chief Financial Officer
CFO Gordon Sangster announces retirement REDWOOD CITY, Calif. , Aug. 06, 2019 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, announces the appointment of Ross Taylor as Senior Vice President and Chief Financial Officer effective August…
read moreSince 2002, Codexis has created new technologies to unlock the power of proteins®. Put our unmatched protein engineering expertise to work for you.
Unlock the power of proteins® with Codexis
Learn More
Company
Industries